129 related articles for article (PubMed ID: 28025110)
21. Chronic exposure to arsenic, LINE-1 hypomethylation, and blood pressure: a cross-sectional study in Bangladesh.
Hossain K; Suzuki T; Hasibuzzaman MM; Islam MS; Rahman A; Paul SK; Tanu T; Hossain S; Saud ZA; Rahman M; Nikkon F; Miyataka H; Himeno S; Nohara K
Environ Health; 2017 Mar; 16(1):20. PubMed ID: 28270149
[TBL] [Abstract][Full Text] [Related]
22. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
23. Multi-generational impacts of arsenic exposure on genome-wide DNA methylation and the implications for arsenic-induced skin lesions.
Guo X; Chen X; Wang J; Liu Z; Gaile D; Wu H; Yu G; Mao G; Yang Z; Di Z; Guo X; Cao L; Chang P; Kang B; Chen J; Gao W; Ren X
Environ Int; 2018 Oct; 119():250-263. PubMed ID: 29982128
[TBL] [Abstract][Full Text] [Related]
24. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
25. 8-Nitroguanine as a potential biomarker for progression of malignant fibrous histiocytoma, a model of inflammation-related cancer.
Hoki Y; Murata M; Hiraku Y; Ma N; Matsumine A; Uchida A; Kawanishi S
Oncol Rep; 2007 Nov; 18(5):1165-9. PubMed ID: 17914567
[TBL] [Abstract][Full Text] [Related]
26. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
Ogishima T; Shiina H; Breault JE; Terashima M; Honda S; Enokida H; Urakami S; Tokizane T; Kawakami T; Ribeiro-Filho LA; Fujime M; Kane CJ; Carroll PR; Igawa M; Dahiya R
Oncogene; 2005 Oct; 24(45):6765-72. PubMed ID: 16007175
[TBL] [Abstract][Full Text] [Related]
27. Health effects of early life exposure to arsenic.
Vahter M
Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):204-11. PubMed ID: 18226075
[TBL] [Abstract][Full Text] [Related]
28. Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2-Cdk7 complex.
Paul S; Banerjee N; Chatterjee A; Sau TJ; Das JK; Mishra PK; Chakrabarti P; Bandyopadhyay A; Giri AK
Metallomics; 2014 Apr; 6(4):864-73. PubMed ID: 24473091
[TBL] [Abstract][Full Text] [Related]
29. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy.
Chanda S; Dasgupta UB; Guhamazumder D; Gupta M; Chaudhuri U; Lahiri S; Das S; Ghosh N; Chatterjee D
Toxicol Sci; 2006 Feb; 89(2):431-7. PubMed ID: 16251483
[TBL] [Abstract][Full Text] [Related]
30. Arsenic exposure and DNA methylation among elderly men.
Lambrou A; Baccarelli A; Wright RO; Weisskopf M; Bollati V; Amarasiriwardena C; Vokonas P; Schwartz J
Epidemiology; 2012 Sep; 23(5):668-76. PubMed ID: 22833016
[TBL] [Abstract][Full Text] [Related]
31. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
32. 15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter.
Liu C; Chen S; Wang X; Chen Y; Tang N
Biochem Pharmacol; 2014 Oct; 91(3):337-47. PubMed ID: 25108236
[TBL] [Abstract][Full Text] [Related]
33. Chronic low level arsenic exposure evokes inflammatory responses and DNA damage.
Dutta K; Prasad P; Sinha D
Int J Hyg Environ Health; 2015 Aug; 218(6):564-74. PubMed ID: 26118750
[TBL] [Abstract][Full Text] [Related]
34. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation.
Reichard JF; Puga A
Epigenomics; 2010 Feb; 2(1):87-104. PubMed ID: 20514360
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic alteration of mitochondrial biogenesis regulatory genes in arsenic exposed individuals (with and without skin lesions) and in skin cancer tissues: A case control study.
Sanyal T; Paul M; Bhattacharjee S; Bhattacharjee P
Chemosphere; 2020 Nov; 258():127305. PubMed ID: 32563914
[TBL] [Abstract][Full Text] [Related]
36. Targeting the 'DNA methylation mark': Analysis of early epigenetic-alterations in children chronically exposed to arsenic.
Sanyal T; Das A; Bhattacharjee S; Gump BB; Bendinskas K; Bhattacharjee P
Sci Total Environ; 2024 Feb; 912():169049. PubMed ID: 38052388
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women.
Engström K; Wojdacz TK; Marabita F; Ewels P; Käller M; Vezzi F; Prezza N; Gruselius J; Vahter M; Broberg K
Arch Toxicol; 2017 May; 91(5):2067-2078. PubMed ID: 27838757
[TBL] [Abstract][Full Text] [Related]
38. Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation.
Gui T; He BS; Gan Q; Yang C
Biotech Histochem; 2017; 92(2):107-114. PubMed ID: 28296552
[TBL] [Abstract][Full Text] [Related]
39. The role of iNOS-mediated DNA damage in infection- and asbestos-induced carcinogenesis.
Hiraku Y; Kawanishi S; Ichinose T; Murata M
Ann N Y Acad Sci; 2010 Aug; 1203():15-22. PubMed ID: 20716278
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis.
Hiraku Y; Kawanishi S
Methods Mol Biol; 2009; 512():3-13. PubMed ID: 19347269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
